Carl Langren
2015
In 2015, Carl Langren earned a total compensation of $1M as Vice President of Finance at NewLink Genetics.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $441,290 |
| Salary | $250,000 |
| Stock Awards | $222,615 |
| Other | $14,625 |
| Total | $1,003,530 |
Langren received $441.3K in option awards, accounting for 44% of the total pay in 2015.
Langren also received $75K in non-equity incentive plan, $250K in salary, $222.6K in stock awards and $14.6K in other compensation.
Rankings
In 2015, Carl Langren's compensation ranked 7,933rd out of 13,638 executives tracked by ExecPay. In other words, Langren earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,933 out of 13,638 | 42nd |
Division Manufacturing | 3,016 out of 5,190 | 42nd |
Major group Chemicals And Allied Products | 1,085 out of 1,854 | 42nd |
Industry group Drugs | 876 out of 1,528 | 43rd |
Industry Pharmaceutical Preparations | 687 out of 1,182 | 42nd |
Source: SEC filing on March 31, 2017.
Langren's colleagues
We found five more compensation records of executives who worked with Carl Langren at NewLink Genetics in 2015.
2015
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2015
Nicholas Vahanian
NewLink Genetics
Chief Medical Officer
2015
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2015
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2015
John Henneman
NewLink Genetics